Stay updated with breaking news from Nasdaq Alks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts forecast that Alkermes plc (NASDAQ:ALKS – Get Rating) will announce earnings per share of $0.03 for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Alkermes’ earnings. The highest EPS estimate is $0.15 and the lowest is ($0.06). Alkermes posted earnings of $0.11 per share during the same quarter last […]
Alkermes plc (NASDAQ:ALKS – Get Rating) shares saw an uptick in trading volume on Wednesday . 97,029 shares changed hands during trading, a decline of 91% from the previous session’s volume of 1,110,160 shares.The stock last traded at $27.05 and had previously closed at $27.99. Several research firms have recently issued reports on ALKS. Mizuho […]
Brokerages expect that Alkermes plc (NASDAQ:ALKS – Get Rating) will post earnings per share of $0.03 for the current quarter, according to Zacks. Five analysts have made estimates for Alkermes’ earnings, with estimates ranging from ($0.06) to $0.15. Alkermes posted earnings of $0.11 per share during the same quarter last year, which suggests a negative […]
CONTENT: Multimedia with summary Many people with Substance Use Disorder are struggling with isolation during the pandemic. Physicians or healthcare providers can provide guidance during these unprecedented times via The National Institute on Drug Abuse (NIDA): https://bit.ly/3siSeCM
CONTENT: Multimedia with summary Though National Cancer Prevention Month has come to an end, Alkermes will not stop working to uncover potential new cancer immunotherapies. Share these tips that may help reduce the risk of cancer and help spread awareness.